ArticleCancer biomarkers : section A of Disease markers2023

Age is a significant biomarker for the selection of neoadjuvant chemotherapy plus radiotherapy versus concurrent chemoradiotherapy in patients with advanced nasopharyngeal carcinoma.

Yihong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.